In gastric cancer, MAGI2-AS3 is negatively associated with overall survival and disease-free survival of cancer patients and promotes epithelial–mesenchymal transition (EMT), cell migration, and invasiveness by sponging miR-141/200a and upregulating the ZEB1 transcription factor [225]. This evidence concerns the gene MAGI2 and cancer.